The MHRA welcomed Health Minister Smyth to its science campus as part of British Science Week to demonstrate how innovations ...

The UK drugs regulator has removed postoperative pain from prolonged-release opioid licences due to increased risks of ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Alyftrek (triple combination medicine ...

A new collaboration between the MHRA and Barts Health NHS Trust has led to introduction a new DNA sequencing technology ...

Vertex Pharmaceuticals’ triple combination cystic fibrosis (CF) treatment has been approved by the Medicines and Healthcare ...

Copenhagen, Denmark Monday, March 10, 2025, 11:00 Hrs [IST] ...

Lawrence Tallon is appointed as the new Chief Executive Officer of Medicines and Healthcare products Regulatory Agency (MHRA). The government has ...

The UK Government has announced the appointment of Lawrence Tallon as the new Chief Executive Officer of the Medicines and ...

The government has announced the appointment of Lawrence Tallon as the new Chief Executive Officer of the Medicines and ...

UK MHRA approves Vertex’s Alyftrek, a once-daily next-in-class CFTR modulator to treat cystic fibrosis: London Monday, March 10, 2025, 10:00 Hrs [IST] Vertex Pharmaceuticals, a ...

Johnson & Johnson’s (J&J) Lazcluze (lazertinib) has been approved by the Medicines and Healthcare products Regulatory Agency ...

The agency approved it based on two Phase III studies showing the drug to be as effective as another combination therapy at improving lung function.